Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Martin

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Ophthalmology|October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationGui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology. Retina|June 17, 2017
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Juan E Grunwald, Benjamin J Kim, et al.
Ophthalmology|April 20, 2012
Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments TrialsJuan E Grunwald, Ebenezer Daniel, Gui-Shuang Ying, et al.
Ophthalmology|November 27, 2018
Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Gui-Shuang Ying, Benjamin J Kim, et al.
Ophthalmology|December 10, 2013
Risk of scar in the comparison of age-related macular degeneration treatments trialsEbenezer Daniel, Cynthia A Toth, Juan E Grunwald, et al.
Ophthalmology|February 19, 2018
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Wei Pan, Gui-Shuang Ying, et al.
Ophthalmology|January 23, 2013
Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)Stephanie A Hagstrom, Gui-Shuang Ying, Gayle J T Pauer, et al.
Ophthalmology. Retina|October 25, 2023
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility StudyKevin J Blinder, Claire Calhoun, Maureen G Maguire, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 10, 2008
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trialStephen J Kim, Wayne R Lo, G Baker Hubbard, et al.
Ophthalmology. Retina|April 25, 2019
Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATTCynthia A Toth, Vincent Tai, Maxwell Pistilli, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Ophthalmology|October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationGui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology. Retina|June 17, 2017
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Juan E Grunwald, Benjamin J Kim, et al.
Ophthalmology|April 20, 2012
Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments TrialsJuan E Grunwald, Ebenezer Daniel, Gui-Shuang Ying, et al.
Ophthalmology|November 27, 2018
Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Gui-Shuang Ying, Benjamin J Kim, et al.
Ophthalmology|December 10, 2013
Risk of scar in the comparison of age-related macular degeneration treatments trialsEbenezer Daniel, Cynthia A Toth, Juan E Grunwald, et al.
Ophthalmology|February 19, 2018
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Wei Pan, Gui-Shuang Ying, et al.
Ophthalmology|January 23, 2013
Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)Stephanie A Hagstrom, Gui-Shuang Ying, Gayle J T Pauer, et al.
Ophthalmology. Retina|October 25, 2023
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility StudyKevin J Blinder, Claire Calhoun, Maureen G Maguire, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 10, 2008
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trialStephen J Kim, Wayne R Lo, G Baker Hubbard, et al.
Ophthalmology. Retina|April 25, 2019
Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATTCynthia A Toth, Vincent Tai, Maxwell Pistilli, et al.
Pageof 12